Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.

CME information and select publications here.

Community discussion

Join the conversation

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

You May Also Like

The Grave Talks | Haunted, Paranormal & Supernatural

HOLOSKY PODCAST

Hidden Brain

Research Insights, a Society of Actuaries Podcast

The Resetter Podcast with Dr. Mindy

Radiowissen

The Best of Coast to Coast AM

The 365 Days of Astronomy

Real Ghost Stories Online

Breaking Down: Collapse